Warning: Undefined array key "file" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Warning: Undefined array key "title" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Warning: Undefined array key "title" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Vorinostat CAS 149647-78-9

High Quality Antineoplastic Drugs Chemical Powder Vorinostat CAS 149647-78-9

 

  • Igama lemveliso:

    Vorinostat CAS 149647-78-9

  • Ibakala:

    Pharmaceutical grade/Cosmetic grade

  • Iinkcazelo ngeempawu:

    umgubo omhlophe

  • Ukupakisha:

    25kg/igubu

  • MOQ:

    1 kilo

  • Ugcino:Indawo eyomileyo epholileyo
  • Beka ubomi kwishelufa:iminyaka eyi-2


Iinkcukacha

Iithegi

Ingcaciso yeMveliso

Vorinostat is a potent HDAC inhibitor with significant applications in cancer treatment, regulating gene expression, and potentially antiviral activities.

  1. HDAC Inhibition: Vorinostat functions by specifically binding to and inhibiting HDAC, including HDAC1, HDAC2, HDAC3 (Class I), and HDAC6 (Class II), thereby altering the acetylation status of histones and other proteins.
  2. Gene Expression Regulation: By inhibiting HDAC activity, Vorinostat helps to restore normal gene expression patterns, which are often disrupted in cancer cells. This leads to cell cycle arrest and apoptosis (programmed cell death) in cancer cells.
  3. Antiviral Activity: Studies have also shown that Vorinostat has the potential to reactivate latent HIV virus in patients, although further research is needed to fully understand and exploit this antiviral property in clinical settings.

 

 

Isicelo
  1. Anticancer Drug: Vorinostat is primarily utilized as an anticancer agent, particularly in the treatment of cutaneous T-cell lymphoma (CTCL), a type of non-Hodgkin's lymphoma that has worsened, persisted, or recurred after two systemic therapies.
  2. FDA Approval: It was approved by the U.S. Food and Drug Administration (FDA) in October 2006 for the treatment of skin cancer, marking it as the first FDA-approved drug for metastatic CTCL when other therapies have failed, the disease has worsened, or has returned.
  3. Combination Therapy: Vorinostat can also be used in combination with other antitumor drugs to enhance their synergistic effects.

 

Iingenelo

Sinemizi-mveliso emininzi ekumgangatho ophezulu enentsebenziswano enzulu, enokubonelela ngeemveliso ezikumgangatho ophezulu kunye namaxabiso akhuphisanayo. Kwaye sinako ukunika izaphulelo zokuthengwa kwezinto ezininzi.Kwaye siyasebenzisana neenkampani ezininzi zokuthunyelwa kwempahla, zinokuzisa iimveliso ngokukhuselekileyo nangokutyibilikayo ezandleni zakho. Ixesha lokuhambisa limalunga neentsuku ezi-3-20 emva kokuqinisekiswa kwentlawulo.

 

Inkcazo

 

Ukuthunyelwa kunye nentlawulo


 

FAQ

1. Ngaba uyifektri okanye inkampani yokurhweba?
Siyinkampani edibanisa ishishini kunye norhwebo, ukubonelela ngenkonzo yokumisa enye.OEM inokwamkelwa.

2. Ngaba ubonelela ngeesampulu? Isimahla okanye yongeziweyo?
Iisampuli zasimahla. Umrhumo womthwalo wesampulu kufuneka uhlawulwe ecaleni kwakho.

3. Ingaba unazo naziphi na izatifikethi ezinxulumene nolawulo lomgangatho?
ISO 9001:2008 isiqinisekiso sokuqinisekisa umgangatho.

4. Ndingenza ntoni ukuze ndifumane ikowuteshini?
I-Pls isazise ngohlobo lwemveliso oyidingayo, ubungakanani beodolo, idilesi kunye neemfuno ezithile. Uqikelelo-mali luya kwenzelwa ireferensi yakho kwangethuba.

5. Loluphi uhlobo lwendlela yokuhlawula oyikhethayo? Ngawaphi amagama amkelweyo?
IMigaqo yoHambiso eyaMkelweyo: FOB,CFR,CIF,EXW;
Imali eyamkelekileyo yeNtlawulo:USD;
Accepted Payment Type: T/T,Western Union; Paypal,BTC
Ulwimi oluthethwayo:IsiNgesi.

 

Ukuba unomdla kwiimveliso zethu, unokukhetha ukushiya ulwazi lwakho apha, kwaye siya kuqhagamshelana nawe kungekudala.


Bhala umyalezo wakho apha kwaye uwuthumele kuthi